实用肝脏病杂志 ›› 2026, Vol. 29 ›› Issue (4): 553-556.doi: 10.3969/j.issn.1672-5069.2026.04.019

• 药物性肝损伤 • 上一篇    下一篇

多烯磷脂酰胆碱联合复方甘草酸苷治疗药物性肝损伤患者疗效研究*

徐国彬, 海花, 孙宏飞, 刘昕   

  1. 028000 内蒙古自治区通辽市人民医院消化内一科(徐国彬,海花);内蒙古民族大学附属医院消化一科(孙宏飞);盘锦市中心医院消化二科(刘昕)
  • 收稿日期:2025-10-22 出版日期:2026-07-10 发布日期:2026-07-20
  • 作者简介:徐国彬,女,46岁,医学硕士,主任医师。E-mail:xuguobin2025@163.com
  • 基金资助:
    *内蒙古自治区公立医院联合科研基金资助项目(编号:2023GLLH0392)

Polyene phosphatidylcholine and compound glycyrrhizin combination in the treatment of patients with drug-induced liver injury

Xu Guobin, Hai Hua, Sun Hongfei, et al   

  1. Section One, Department of Gastroenterology, People's Hospital, Tongliao 028000, Inner Mongolia Autonomous Region, China
  • Received:2025-10-22 Online:2026-07-10 Published:2026-07-20

摘要: 目的 观察应用多烯磷脂酰胆碱联合复方甘草酸苷治疗药物性肝损伤(DILI)患者的临床疗效。方法 2023年1月~2024年12月我院收治的122例DILI患者被随机分为对照组61例和观察组61例,分别给予多烯磷脂酰胆碱注射液或多烯磷脂酰胆碱注射液联合复方甘草酸苷注射液治疗2~6周。采用放射免疫法检测血清超氧化物歧化酶(SOD)水平,采用生化比色法检测血清丙二醛(MDA)水平,采用速率法检测血清谷胱甘肽过氧化物酶(GSH-Px)水平,采用ELISA法检测血清白细胞介素(IL)-6、IL-1β和肿瘤坏死因子-α(TNF-α)水平。以治疗4周药品费用/生化有效率计算成本-效益比。结果 在治疗后,观察组血清ALT、AST和ALP水平分别为(56.2±9.3)U/L、(46.3±9.8)U/L和(90.6±10.2)U/L,均显著低于对照组【分别为(69.1±10.7)U/L、(59.5±10.2)U/L和(109.3±11.3)U/L,P<0.05】;观察组血清SOD和GSH-Px水平分别为(95.1±10.4)U/mL和(119.7±13.1)μmol/L,均显著高于对照组【分别为(73.4±9.2)U/mL和(95.3±11.9)μmol/L,P<0.05】,而血清MDA水平为(2.7±0.6)μmol/L,显著低于对照组【(3.8±0.7)μmol/L,P<0.05】;观察组血清IL-6、IL-1β和TNF-α水平分别为(7.2±1.6)pg/mL、(16.5±3.1)ng/mL和(7.5±1.8)pg/mL,均显著低于对照组【分别为(9.8±1.9)pg/mL、(22.4±4.0)ng/mL和(11.3±2.1)pg/mL,均P<0.05】;观察组药品花费稍高于对照组,但治疗有效率为98.4%,显著高于对照组的59.0%(P<0.05)。结论 应用多烯磷脂酰胆碱联合复方甘草酸苷治疗DILI患者临床疗效更好,可能与减轻了氧化应激和细胞因子反应有关。

关键词: 药物性肝损伤, 多烯磷脂酰胆碱, 复方甘草酸苷, 氧化应激, 细胞因子, 治疗

Abstract: Objective The aim of this study was to investigate the clinical efficacy of polyene phosphatidylcholine in combination with compound glycyrrhizin in the treatment of patients with drug-induced liver injury (DILI). Methods 122 patients with DILI were encountered in our hospital between January 2023 and December 2024, and were randomly assigned to receive intravenous polyene phosphatidylcholine in control (n=61), or receive intravenous polyene phosphatidylcholine and compound glycyrrhizin combination in observation (n=61) for two to six weeks. Serum superoxide dismutase (SOD) level was measured by radioimmunoassay, serum malondialdehyde (MDA) level was determined by biochemical colorimetry and serum glutathione peroxidase (GSH-Px) level was detected by velocity method. Serum interleukin (IL)-6, IL-1β and tumor necrosis factor-α (TNF-α) levels were measured by ELISA. Cost/efficacy was calculated by medicine cost/effectiveness. Results By end of average four-week treatment, serum ALT, AST and ALP levels in the observation group were (56.2±9.3)U/L, (46.3±9.8)U/L and (90.6±10.2)U/L, all much lower than [(69.1±10.7)U/L, (59.5±10.2)U/L and (109.3±11.3)U/L, respectively, P<0.05] in the control; serum SOD and GSH-Px levels were (95.1±10.4)U/mL and (119.7±13.1)μmol/L, both significantly higher than [(73.4±9.2)U/mL and (95.3±11.9)μmol/L, respectively, P<0.05], while serum MDA level was (2.7±0.6)μmol/L, significantly lower than [(3.8±0.7)μmol/L, P<0.05] in the control; serum IL-6, IL-1β and TNF-α levels were (7.2±1.6)pg/mL, (16.5±3.1)ng/mL and (7.5±1.8)pg/mL, all significantly lower than [(9.8±1.9)pg/mL, (22.4±4.0)ng/mL and (11.3±2.1)pg/mL, respectively, P<0.05] in the control group; medical cost in the observation group was higher than in the control, but the treatment effectiveness rate was 98.4%, much higher than 59.0%(P<0.05) in the control group. Conclusion Combination of polyene phosphatidylcholine and compound glycyrrhizin in dealing with patients with DILI could get a satisfactory effectiveness, which might be related to inhibition of oxidative stress and cytokine reactions.

Key words: Drug-induced liver injury, Polyene phosphatidylcholine, Compound glycyrrhizin, Oxidative stress, Cytokines, Therapy